Which research presented at the annual congress of the European League Against Rheumatism in Madrid interested you the most?
50% of patients with RA discontinued biologics within 2 years
Psoriatic arthritis patients displayed response to apremilast up to 1 year
Abatacept, adalimumab effectively treated RA patients comparably
13% of high-risk OTC NSAID users faced serious adverse events
Vote
View Results
See this poll on:
https://poll.fm/7271846/embed